Skip to content

4Accepted Oct 20, 4:33 PM ET

Cytokinetics Inc: director Harrington Robert Arthur received 195 shares

CYTKCYTOKINETICS INC

Accepted (ET)

4:33 PM

Oct 20, 2026

Filed

Oct 20, 2026

Documents

1

Size

4.6 KB

Summary

Cytokinetics Inc: director Harrington Robert Arthur received 195 shares

Updated

What happened Harrington Robert Arthur, a director, received 195 shares (transaction code A) on Oct 16, 2026 at $63.92 per share, for $12,464, according to the Form 4 filed Oct 20, 2026.

Key details

  • Transaction date and price: Oct 16, 2026; $63.92 per share; total $12,464.
  • Transaction code: A (award/acquisition).
  • Shares owned after the transaction: not reported in the Form 4.
  • Footnote: director equity in lieu of cash retainer program (F1).
  • Form 4 filing date: Oct 20, 2026.

Why it may matter

  • The filing reports an award under the company's director equity in lieu of cash retainer program, which is a compensation issuance rather than a market purchase or sale.
    A filing does not show why the insider traded or why the company acted.

AI-written summary · check the filing